Stage III
In vivo animal studies
Eye drops containing a new medicinal product or a new type of carrier cannot be administered to the human eye without prior assessment of their safety and efficacy following administration to an animal eye. Accordingly, before the formulation proceeds to clinical trials in humans, it will be administered to the eyes of pigs, whose ocular anatomy is among the most similar to that of humans. This stage has already been preceded by safety studies in cell cultures (in vitro) and studies of the carrier alone (placebo) in rabbits.